{"filing":{"accession_number":"0001193125-26-352346","cik":"0001095981","ticker":"PSTV","company_name":"CERENOME, INC.","form":"8-K","filing_date":"2026-08-14","report_date":"2026-08-14","primary_document":"pstv-20260814.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1095981/000119312526352346/pstv-20260814.htm"},"events":[{"id":27945,"run_id":25522,"accession_number":"0001193125-26-352346","anchor_item_number":"2.02","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"summary":"This is a clear earnings release disclosing Q2 2026 financial results for Cerenome, Inc. The filing reports operating loss of $9.1 million (vs. $1.5 million in Q2 2025), net loss of $9.0 million or $1.31 per share (vs. net income of $5.2 million in Q2 2025), and cash position of $8.6 million as of June 30, 2026. The press release includes condensed consolidated financial statements and is furnished as Exhibit 99.1 under Item 2.02, which is the standard Item for earnings disclosures. The material deterioration in operating results and significant cash burn are material to investors assessing the company's financial condition.","company_name":"CERENOME, INC.","ticker":"PSTV","filing_date":"2026-08-14","form":"8-K","submitted_at":null,"items":[{"id":29677,"accession_number":"0001193125-26-352346","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"This is a clear earnings release disclosing Q2 2026 financial results for Cerenome, Inc. The filing reports operating loss of $9.1 million (vs. $1.5 million in Q2 2025), net loss of $9.0 million or $1.31 per share (vs. net income of $5.2 million in Q2 2025), and cash position of $8.6 million as of June 30, 2026. The press release includes condensed consolidated financial statements and is furnished as Exhibit 99.1 under Item 2.02, which is the standard Item for earnings disclosures. The material deterioration in operating results and significant cash burn are material to investors assessing the company's financial condition.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-14T20:34:49.243241+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":29677,"accession_number":"0001193125-26-352346","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"This is a clear earnings release disclosing Q2 2026 financial results for Cerenome, Inc. The filing reports operating loss of $9.1 million (vs. $1.5 million in Q2 2025), net loss of $9.0 million or $1.31 per share (vs. net income of $5.2 million in Q2 2025), and cash position of $8.6 million as of June 30, 2026. The press release includes condensed consolidated financial statements and is furnished as Exhibit 99.1 under Item 2.02, which is the standard Item for earnings disclosures. The material deterioration in operating results and significant cash burn are material to investors assessing the company's financial condition.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-14T20:34:49.243241+00:00","company_name":"CERENOME, INC.","ticker":"PSTV","filing_date":"2026-08-14"}]}